SAN CLEMENTE, Calif. (AP) _ Glaukos Corp. (GKOS) on Thursday reported fourth-quarter net income of $36.6 million.
On a per-share basis, the San Clemente, California-based company said it had net income of 84 cents. Losses, adjusted for non-recurring gains, were 6 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The glaucoma treatments developer posted revenue of $65.8 million in the period.
For the year, the company reported net income of $15.4 million, or 37 cents per share, swinging to a profit in the period. Revenue was reported as $237 million.
Glaukos expects full-year revenue in the range of $290 million to $300 million.
Glaukos shares have increased 13% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $61.31, a fall of nearly 10% in the last 12 months.